Virology Testing Market Detailed In New Research Report 2023

Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified.

Virology Testing Market- Market Dynamics

Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course.

According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual epidemics about 3 to 5 million cases with severe stage of illness, which results in the 290 000 to 650 000 deaths worldwide annually. Although rapid diagnostic tests are majorly used, PCR based techniques are being adopted for detection of influenza.

According Report on Global Sexually Transmitted Infection Surveillance published in 2015 by WHO, in 2012, an estimated 357 million new infections, which is equivalent to roughly 1 million patients per day were reported for the four curable sexually transmitted disease such as chlamydia, gonorrhea, syphilis, and trichomoniasis.

Virology Testing Market - Regional Insights

On the basis of Geography, virology testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to dominate the virology testing market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection in 2015.

According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visit to physician for treatment of infectious and parasitic diseases in U.S. Moreover, according to a study from the Society for Risk Analysis, 2016, GDP loss of a viral pandemic outbreak in the U.S. was recorded between US$ 34.4 billion and US$ 45.3 billion in 2015.

Comments

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Increasing various research activities is propelling growth of the pediatric vaccines market

Pediatric Vaccine Market: Global Trends Over the course of the forecast period, rising public awareness of vaccinations and immunisation is anticipated to fuel market expansion for paediatric vaccines worldwide. For instance, the United States recognises January as Cervical Health Awareness Month, promoting the value of routine immunisation and screening in the fight against cancer. Global Pediatric Vaccine Market: Drivers Increasing awareness regarding vaccines and immunization among the populace is expected to boost growth of the global pediatric vaccine market over the forecast period. For instance, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded.

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: · Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe · Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe · Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering takes place and which layer of skin is affected. Global epidermolysis bullosa market is estimated to be valued at US$ 3,

Healthcare News

Search This Blog